Intraoperative Injection of Technetium-99m Sulfur Colloid for Sentinel Lymph Node Biopsy in Breast Cancer Patients: A Single Institution Experience

<table class="algorithm-group"><tr><td><table class="algorithm" id="figbox1"><tr><td colspan="2">(1) Patient factors</td></tr><tr><td colspan="2"> (i) Decreased discomfort as patient is under anesthesia</td></tr><tr><td colspan="2"> (ii) Improved logistics as patient does not need to go to nuclear medicine</td></tr><tr><td colspan="2">(2) Surgeon factors</td></tr><tr><td colspan="2"> (i) Can have a first case start time and no case delay due to nuclear medicine schedule</td></tr></table></td></tr></table>

<div>Advantages of intraoperative radioisotope injection.</div>

Surgery Research and Practice

figbox1

Box 1

Box 1: Intraoperative Injection of Technetium-99m Sulfur Colloid for Sentinel Lymph Node Biopsy in Breast Cancer Patients: A Single Institution Experience 

Box 1 | Intraoperative Injection of Technetium-99m Sulfur Colloid for Sentinel Lymph Node Biopsy in Breast Cancer Patients: A Single Institution Experience 